Jacobs Levy Equity Management
REPL icon

Jacobs Levy Equity Management’s Replimune Group REPL Stock Holding History

Jacobs Levy Equity Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,199
Closed -$177K – 1050
2026
Q1 		$177K Buy
+23,199
New +$177K ﹤0.01% 923
2024
Q4 		– Sell
-39,521
Closed -$433K – 1028
2024
Q3 		$433K Sell
39,521
-44,153
-53% -$448K ﹤0.01% 852
2024
Q2 		$753K Sell
83,674
-49,521
-37% -$345K ﹤0.01% 790
2024
Q1 		$1.09M Buy
+133,195
New +$1.09M ﹤0.01% 701

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Jacobs Levy Equity Management's REPL Position: Q2 2026 in Review

Jacobs Levy Equity Management sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 23,199 shares — an estimated $177K sold.

Jacobs Levy Equity Management first reported a position in REPL in Q1 2024 and held it in 4 quarters. The position peaked at $1.09M in Q1 2024. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Jacobs Levy Equity Management reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 23,199 Replimune Group shares in Q2 2026, an estimated $177K.
  • Jacobs Levy Equity Management first reported a position in Replimune Group in Q1 2024 and held it in 4 quarters.
  • Jacobs Levy Equity Management's Replimune Group position peaked at $1.09M in Q1 2024.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.